<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02648061</url>
  </required_header>
  <id_info>
    <org_study_id>2015/1807</org_study_id>
    <nct_id>NCT02648061</nct_id>
  </id_info>
  <brief_title>Transitions Between Clinical Circulatory States After Out-of-hospital Cardiac Arrest</brief_title>
  <official_title>Transitions Between Clinical Circulatory States After Out-of-hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extensive research exists for cardio-pulmonary resuscitation (CPR) and the chance of&#xD;
      successful return of spontaneous circulation (ROSC) is improved. Unfortunately, the overall&#xD;
      prognosis after ROSC has not improved much and the in-hospital mortality is still reported to&#xD;
      be 50 to 70 %. The &quot;post-resuscitation disease&quot; is now called the &quot;post-cardiac arrest&#xD;
      syndrome&quot; (PCAS) and comprises 1) brain injury, 2) myocardial dysfunction and 3) systemic&#xD;
      ischemia and reperfusion.&#xD;
&#xD;
      Treatment of patients after cardiac arrest has often followed guidelines that were primarily&#xD;
      developed for treatment of septic shock. It is still uncertain whether this is the optimal&#xD;
      way to deliver circulatory support after cardiac arrest.&#xD;
&#xD;
      There is a lack of studies assessing the relationship between the inflammatory response&#xD;
      measured by inflammatory biomarkers and circulatory failure in PCAS.&#xD;
&#xD;
      In this study a detailed description will be given of the clinical trajectory of the&#xD;
      circulation and the inflammatory response during the first 5 days after cardiac arrest, and&#xD;
      it will be investigated whether patterns of circulatory and inflammatory response may be&#xD;
      predictive of deterioration of clinical state.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will obtain longitudinally advanced hemodynamic observations with high resolution&#xD;
      during the acute phase of post cardiac arrest syndrome (PCAS), and analyze the details in&#xD;
      clinical transitions related to circulatory failure. The study will also analyze the&#xD;
      relationship between inflammatory biomarkers and circulatory failure in PCAS and kinetics of&#xD;
      hemodynamics associated with standard interventions in the intensive care unit (ICU).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time in clinical circulatory state (stable, unstable, severe unstable)</measure>
    <time_frame>5 days</time_frame>
    <description>These clinical circulatory states are defined as follows: 1) Stable circulation (Mean blood pressure &gt; 65 mmHg, heart rate 51-100, lactate serum concentrations &lt; 2 mmol/l, ScvO2 &gt; 65, fluid administration &lt; 0.5 l/h, norepinephrine dose &lt; 0.1 microgram/kg/min, no other vasoactive drugs.&#xD;
2) Unstable circulation (mean blood pressure 45-64 mmHg , heart rate 41-50, 101-130, lactate serum concentrations 2-4 mmol/l, ScvO2 &gt; 50-64, fluid administration 0.5-1,9 l/h, norepinephrine dose 0.1-0.29 microgram/kg/min, Dobutamin &gt; 10 microgram/kg/min, no other vasoactive drugs) 3) Severe unstable circulation (mean blood pressure &lt; 45 mmHg , heart rate &lt; 40, &gt; 130, lactate serum concentrations &gt;4 mmol/l, ScvO2 &lt; 50, fluid administration &gt; 2.0 l/h, norepinephrine dose 0.3 or above microgram/kg/min, dobutamin &gt; 10 microgram/kg/min, other vasoactive drugs, use of aortic balloon pump).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6 in relation to dose of Norepinephrine used to correct vasoplegia after cardiac arrest</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Out-of-Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>After cardiac arrest syndrome (ACAS)</arm_group_label>
    <description>adult patients after out-of-hospital cardiac arrest</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients who are admitted to either the Intensive Care Unit (ICU) or the Coronary&#xD;
        Care Unit (CCU) at St. Olav's University Hospital, Trondheim, Norway, after out-of-hospital&#xD;
        cardiac arrest will be considered for inclusion.(catchment population of 700,000)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest (OHCA)&#xD;
&#xD;
          -  Admitted to Coronary Care Unit (CCU) or Intensive Care Unit (ICU), St. Olav's&#xD;
             University Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sepsis within 24 hours before cardiac arrest&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Decision of withdrawal or withholding of life prolonging therapy (i.e. due to advanced&#xD;
             malignancy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toril Hernes, prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs Hospital Trondheim University Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Langeland H, Bergum D, Nordseth T, Løberg M, Skaug T, Bjørnstad K, Gundersen Ø, Skjærvold NK, Klepstad P. Circulatory trajectories after out-of-hospital cardiac arrest: a prospective cohort study. BMC Anesthesiol. 2021 Sep 8;21(1):219. doi: 10.1186/s12871-021-01434-2.</citation>
    <PMID>34496748</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 4, 2015</study_first_submitted>
  <study_first_submitted_qc>January 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2016</study_first_posted>
  <last_update_submitted>September 11, 2021</last_update_submitted>
  <last_update_submitted_qc>September 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood circulation</keyword>
  <keyword>Follow-up studies</keyword>
  <keyword>Biological markers</keyword>
  <keyword>Hemodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

